SCHEMBL1630352

SCHEMBL1630352

O=C(Nc1ccccc1-n1nccc1-c1ccc(O)cc1O)c1ccncc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.45
RAB9A P51151 2/20 0.44
KMT2A Q03164 3/20 0.43
HSD17B10 Q99714 2/20 0.43
TP53 P04637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KCNMA1 Q12791 1/20 0.42
TYR P14679 1/20 0.42
POLB P06746 1/20 0.41
HSP90AA1 P07900 1/20 0.41
ALDH1A1 P00352 2/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
LMNA P02545 2/20 0.39
HTT P42858 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
KDM4E B2RXH2 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HDAC2 Q92769 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629175 0.93 TYR (0.48) HDAC1HSD17B10TP53NPSR1KCNMA1
SCHEMBL1629234 0.89 HDAC1 (0.50) HDAC1RAB9ATP53KCNMA1ALDH1A1
SCHEMBL1629709 0.80 KCNQ2 (0.51) KMT2ANPSR1ALDH1A1LMNAHTT
SCHEMBL1629986 0.80 GAA (0.50) RAB9AKMT2AHSD17B10POLBLMNA
SCHEMBL1628592 0.80 KCNK3 (0.49) RAB9AKMT2AHSD17B10TP53POLB
SCHEMBL1631613 0.78 HSP90AA1 (0.46) HDAC1RAB9AHSD17B10NPSR1KCNMA1
SCHEMBL1629510 0.76 TYR (0.48) RAB9AKMT2ATP53TYRPOLB
SCHEMBL1631545 0.75 HSP90AA1 (0.47) KMT2ATYRHSP90AA1
SCHEMBL1630006 0.74 MAPT (0.45) KMT2AHSD17B10POLBHSP90AA1ALDH1A1
SCHEMBL1630445 0.74 POLB (0.48) RAB9AKMT2ATYRPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HDAC1 189/4885RAB9A 2251/4885KMT2A 4362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.